| Profile | GDS5420 / 221094_s_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 285.39 | 58 |
| GSM1296119 | B_lesional_pre-dose | 384.24 | 63 |
| GSM1296076 | C_lesional_pre-dose | 318.68 | 61 |
| GSM1296092 | D_lesional_pre-dose | 465.08 | 67 |
| GSM1296103 | E_lesional_pre-dose | 398.96 | 64 |
| GSM1296078 | F_lesional_pre-dose | 308.33 | 61 |
| GSM1296107 | G_lesional_pre-dose | 390.25 | 63 |
| GSM1296109 | H_lesional_pre-dose | 347.69 | 61 |
| GSM1296080 | I_lesional_pre-dose | 249.14 | 57 |
| GSM1296090 | J_lesional_pre-dose | 400.79 | 65 |
| GSM1296074 | K_lesional_pre-dose | 376.9 | 64 |
| GSM1296111 | L_lesional_pre-dose | 411.56 | 64 |
| GSM1296099 | M_lesional_pre-dose | 331.25 | 60 |
| GSM1296086 | O_lesional_pre-dose | 350.79 | 63 |
| GSM1296117 | P_lesional_pre-dose | 401.06 | 64 |
| GSM1296113 | Q_lesional_pre-dose | 363 | 62 |
| GSM1296096 | R_lesional_pre-dose | 390.29 | 63 |
| GSM1296105 | S_lesional_pre-dose | 206.33 | 52 |
| GSM1296098 | T_lesional_pre-dose | 201.36 | 52 |
| GSM1296101 | U_lesional_pre-dose | 269.3 | 57 |
| GSM1296121 | V_lesional_pre-dose | 324.64 | 60 |
| GSM1296088 | W_lesional_pre-dose | 313.49 | 60 |
| GSM1296082 | X_lesional_pre-dose | 432.69 | 66 |
| GSM1296115 | Y_lesional_pre-dose | 372.4 | 63 |
| GSM1296084 | Z_lesional_pre-dose | 302.75 | 59 |
| GSM1296072 | B_lesional_day8 | 269.66 | 57 |
| GSM1296069 | L_lesional_day8 | 446.22 | 65 |
| GSM1296071 | P_lesional_day8 | 270.04 | 56 |
| GSM1296070 | Y_lesional_day8 | 316.28 | 59 |
| GSM1296073 | V_lesional_day8 | 363.08 | 63 |
| GSM1296034 | A_lesional_day15 | 166.74 | 48 |
| GSM1296041 | G_lesional_day15 | 366.12 | 62 |
| GSM1296035 | R_lesional_day15 | 389.45 | 63 |
| GSM1296038 | U_lesional_day15 | 296.66 | 59 |
| GSM1296047 | B_lesional_day15 | 261.93 | 56 |
| GSM1296039 | E_lesional_day15 | 485.43 | 68 |
| GSM1296042 | H_lesional_day15 | 278.11 | 57 |
| GSM1296043 | L_lesional_day15 | 312.46 | 59 |
| GSM1296037 | M_lesional_day15 | 263.51 | 56 |
| GSM1296046 | P_lesional_day15 | 276.32 | 56 |
| GSM1296044 | Q_lesional_day15 | 312.94 | 59 |
| GSM1296045 | Y_lesional_day15 | 349.1 | 61 |
| GSM1296025 | C_lesional_day15 | 205.51 | 53 |
| GSM1296033 | D_lesional_day15 | 262.25 | 57 |
| GSM1296027 | I_lesional_day15 | 153.55 | 50 |
| GSM1296032 | J_lesional_day15 | 318.24 | 60 |
| GSM1296024 | K_lesional_day15 | 181.57 | 52 |
| GSM1296031 | W_lesional_day15 | 325.84 | 60 |
| GSM1296028 | X_lesional_day15 | 218.22 | 54 |
| GSM1296029 | Z_lesional_day15 | 300.43 | 59 |
| GSM1296026 | F_lesional_day15 | 259.72 | 58 |
| GSM1296030 | O_lesional_day15 | 197.46 | 54 |
| GSM1296040 | S_lesional_day15 | 263.58 | 57 |
| GSM1296036 | T_lesional_day15 | 171.63 | 49 |
| GSM1296048 | V_lesional_day15 | 452.56 | 66 |
| GSM1296059 | A_lesional_day43 | 265.67 | 57 |
| GSM1296066 | G_lesional_day43 | 326.49 | 60 |
| GSM1296060 | R_lesional_day43 | 356.24 | 62 |
| GSM1296063 | U_lesional_day43 | 367.7 | 63 |
| GSM1296064 | E_lesional_day43 | 390.24 | 64 |
| GSM1296067 | H_lesional_day43 | 252.87 | 55 |
| GSM1296062 | M_lesional_day43 | 269.76 | 57 |
| GSM1296068 | Q_lesional_day43 | 324.7 | 59 |
| GSM1296050 | C_lesional_day43 | 257.64 | 57 |
| GSM1296057 | D_lesional_day43 | 371.46 | 62 |
| GSM1296052 | I_lesional_day43 | 176.59 | 52 |
| GSM1296054 | J_lesional_day43 | 187.47 | 51 |
| GSM1296049 | K_lesional_day43 | 235.37 | 55 |
| GSM1296055 | W_lesional_day43 | 354.16 | 61 |
| GSM1296053 | X_lesional_day43 | 158.91 | 49 |
| GSM1296058 | Z_lesional_day43 | 278.33 | 58 |
| GSM1296051 | F_lesional_day43 | 323.84 | 61 |
| GSM1296056 | O_lesional_day43 | 505.98 | 68 |
| GSM1296065 | S_lesional_day43 | 381.69 | 63 |
| GSM1296061 | T_lesional_day43 | 184.5 | 50 |
| GSM1296095 | A_non-lesional_pre-dose | 333.43 | 61 |
| GSM1296120 | B_non-lesional_pre-dose | 346.45 | 61 |
| GSM1296077 | C_non-lesional_pre-dose | 158.96 | 49 |
| GSM1296093 | D_non-lesional_pre-dose | 182.26 | 50 |
| GSM1296104 | E_non-lesional_pre-dose | 343.79 | 61 |
| GSM1296079 | F_non-lesional_pre-dose | 210.69 | 54 |
| GSM1296108 | G_non-lesional_pre-dose | 350.51 | 61 |
| GSM1296110 | H_non-lesional_pre-dose | 202.01 | 50 |
| GSM1296081 | I_non-lesional_pre-dose | 168.85 | 51 |
| GSM1296091 | J_non-lesional_pre-dose | 261.72 | 57 |
| GSM1296075 | K_non-lesional_pre-dose | 269.09 | 58 |
| GSM1296112 | L_non-lesional_pre-dose | 277.78 | 56 |
| GSM1296100 | M_non-lesional_pre-dose | 221.69 | 53 |
| GSM1296087 | O_non-lesional_pre-dose | 143.02 | 49 |
| GSM1296118 | P_non-lesional_pre-dose | 264.78 | 56 |
| GSM1296114 | Q_non-lesional_pre-dose | 313.64 | 59 |
| GSM1296097 | R_non-lesional_pre-dose | 295.97 | 59 |
| GSM1296106 | S_non-lesional_pre-dose | 240.27 | 54 |
| GSM1296102 | U_non-lesional_pre-dose | 211.53 | 52 |
| GSM1296122 | V_non-lesional_pre-dose | 292.92 | 58 |
| GSM1296089 | W_non-lesional_pre-dose | 272.49 | 57 |
| GSM1296083 | X_non-lesional_pre-dose | 224.55 | 54 |
| GSM1296116 | Y_non-lesional_pre-dose | 318.85 | 59 |
| GSM1296085 | Z_non-lesional_pre-dose | 195.12 | 52 |